Company Hires Miranda Mann Porter, Ph.D., as COO 

Elligo Health Research, today announced the acquisition of Root Health, an AI virtual assistant for clinical research. The acquisition of Root Health adds to Elligo’s commitment of building a technology-forward, integrated healthcare-enabling research organization with a full range of capabilities to improve the efficiency of clinical research and is designed to support easy access for faster enrollment and accelerated trials overall. 

“Root Health’s AI virtual assistant fits seamlessly with Elligo’s proprietary IntElligo Research Stack,” said Root Health CEO Raj Sharma. “Root Health was built to improve the patient’s experience in clinical trials while accelerating patient recruitment. Together, we will build stronger healthcare communities and bring clinical research as care to more patients.” 

In addition, Elligo announced the addition of COO Miranda Mann Porter, Ph.D., to its leadership team. Porter is an experienced global leader with a diverse background in therapeutics (CNS), operational execution of clinical development programs and Phase I-IV trials, post-marketing medical affairs services, and healthcare delivery. 

Porter was most recently with Syneos Health in a series of roles of increasing responsibility, including Executive Vice President & General Manager, Asia Pacific, where she rebuilt regional CRO leadership and infrastructure across 13 countries. She is experienced in all stages of the M&A process, with strong engagement in strategic planning, execution, and post-deal operational integration. 

“Our acquisition of Root Health is yet another example of our tireless efforts to better support our patients and the physician practice networks that serve them,” said John Potthoff, Ph.D., CEO of Elligo. “And Miranda brings a wealth of experience to the COO role as we continue to build out our team and hire the best minds in the industry. We look forward to continuing to expand our leadership team, technologies, and service offerings as we further our mission to ensure that all patients have access to clinical trials as a care option.” 

About Elligo Health Research^®
Elligo Health Research, a healthcare-enabling research organization, uses electronic health records and the trusted patient and physician relationship to ensure all patients have access to clinical research as a care option. Powered by our Goes Direct^® approach and novel IntElligo^® Research Stack clinical technology, our team provides access to the best healthcare experts, patients, and research technologies. We engage physicians and patients who otherwise would not participate in clinical research and accelerate the development of new pharmaceutical, biotechnology, and medical device and diagnostic products. Learn more at elligodirect.com.